StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) shareholders

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.01−0.02 (-1.94%)

Close on Nov 17, 2026Market cap $176.01MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
99.5%
173M of 174M shares
Institutional holders
124
50 new, 21 sold out
Net institutional buying
35M
In Q2 2026
Insider trades, 12 months
10 buys · 4 sales
Net sold $123.87K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
RA Capital Management, L.P.
Joint filing with Peter Kolchinsky (9.90%), Rajeev Shah (9.90%) and 1 more
17,620,4799.90%13G (passive) amendmentMar 31, 2026
Rajeev Shah
Joint filing with RA Capital Management, L.P. (9.90%), Peter Kolchinsky (9.90%) and 1 more
15,746,8299.90%13G (passive) amendmentDec 31, 2025
Soleus Capital, LLC
Joint filing with Soleus Capital Master Fund, L.P. (8.60%), Soleus Capital Group, LLC (8.60%) and 3 more
14,996,1548.60%13G (passive) amendmentSep 30, 2026
Janus Henderson Group PLC
Joint filing with Janus Henderson Biotech Innovation Master Fund Ltd (6.00%)
14,885,4219.99%13G (passive)Nov 28, 2025
Perceptive Advisors LLC
Joint filing with Joseph Edelman (7.90%), Perceptive Life Sciences Master Fund, Ltd. (7.90%)
14,113,8637.90%13G (passive) amendmentMar 31, 2026
Michael Kramarz
Joint filing with Commodore Capital LP (7.20%), Commodore Capital Master LP (7.20%) and 1 more
12,366,7767.20%13G (passive) amendmentMar 31, 2026
Point72 Capital Advisors, Inc.
Joint filing with Point72 Asset Management, L.P. (7.00%), Steven A. Cohen (7.00%)
10,495,2527.00%13G (passive) amendmentDec 31, 2025
BlackRock, Inc.10,436,7606.00%13G (passive)Jun 30, 2026
Deep Track Capital, LP
Joint filing with David Kroin (9.99%), Deep Track Biotechnology Master Fund, Ltd. (6.49%)
10,012,9589.99%13G (passive)Oct 1, 2025
Commodore Capital LP
Joint filing with Commodore Capital Master LP (9.90%), Robert Egen Atkinson (9.90%) and 1 more
9,690,6659.90%13G (passive)Oct 1, 2025
Octagon Investments Master Fund LP
Joint filing with Octagon Capital Advisors LP (6.40%), Ting Jia (6.40%)
9,567,8986.40%13G (passive)Dec 31, 2025
Franklin Advisers, Inc.
Joint filing with Franklin Resources, Inc. (6.00%)
9,163,9906.00%13G (passive)Dec 31, 2025
Vanguard Capital Management8,995,8055.16%13G (passive)Sep 30, 2026
Columbia Management Investment Advisers, LLC
Joint filing with Ameriprise Financial, Inc. (5.30%)
8,711,3855.30%13G (passive)Mar 31, 2026
Matthew Sesterhenn
Joint filing with Squadron Capital Management LLC (8.50%), William Blank (8.50%) and 1 more
8,250,0008.50%13G (passive)Oct 1, 2025
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
285,4179.99%13G (passive) amendmentDec 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of PALIValueChange% of portfolio
Soleus Capital Management, L.P.13,063,6877.50%$27.30MNew0.94%
B Group, Inc.11,414,2856.55%$23.86M–11.20%
Ameriprise Financial Inc11,081,4346.36%$23.16M−428,8860.00%
Jupiter Topco LLC10,689,4526.13%$22.39MNew0.01%
BlackRock, Inc.10,436,7605.99%$21.81M+8,560,4200.00%
Octagon Capital Advisors LP10,276,3175.90%$21.48M–1.93%
Perceptive Advisors LLC8,425,0654.83%$17.61M−503,0840.26%
Ra Capital Management, L.P.7,124,1164.09%$14.89M–0.13%
Franklin Resources Inc5,785,1893.32%$12.09M–0.00%
Point72 Asset Management, L.P.5,253,4033.01%$10.98M+4,841,6310.01%
Boxer Capital Management, LLC4,799,8752.75%$10.03M–0.76%
Adage Capital Partners Gp, L.L.C.4,500,0002.58%$9.41M–0.01%
Eversept Partners, LP4,182,7852.40%$8.74M−804,7140.45%
Geode Capital Management, LLC3,760,4852.16%$7.86M+2,214,2450.00%
Wellington Management Group Llp3,703,9362.13%$7.74M+799,0250.00%
Goldman Sachs Group Inc3,578,0202.05%$7.48M−1,795,9310.00%
Federated Hermes, Inc.3,136,6071.80%$6.56M–0.01%
Squadron Capital Management LLC3,000,0001.72%$6.27M–1.95%
Propel Bio Management, LLC2,582,3881.48%$5.40M+1,467,3882.82%
Vestal Point Capital, LP2,500,0001.43%$5.23M–0.12%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026124173M99.5%50 / 3324 / 2158M23M
Q1 202696149M85.8%31 / 3025 / 2049M34M
Q4 202586136M78.0%75 / 71 / 1136M0M
Q3 2025120M0.1%2 / 71 / 10M0M
Q2 2025110M0.0%3 / 23 / 50M0M
Q1 2025130M0.2%4 / 51 / 10M0M
Q4 2024100M0.1%2 / 41 / 10M0M
Q3 202490M0.1%1 / 31 / 00M0M
Q2 202480M0.0%8 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

62 funds held PALI in Q2 2026, 50% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of PALIValue% of fundAs of
iShares Russell 2000 ETF3,729,1342.14%$7.79M0.01%Jun 30, 2026
Federated Hermes Kaufmann Small Cap Fund3,136,6071.80%$5.94M0.21%Jul 31, 2026
Franklin Biotechnology Discovery Fund2,119,9101.22%$4.02M0.35%Jul 31, 2026
Vanguard Extended Market Index Fund1,722,8170.99%$3.60M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund1,610,0250.92%$3.05M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF1,117,6240.64%$2.34M0.02%Jun 30, 2026
Nuveen Equity Index Fund773,1960.44%$1.47M0.00%Jul 31, 2026
Fidelity Extended Market Index Fund667,0040.38%$1.41M0.00%May 31, 2026
iShares Micro-Cap ETF495,8480.28%$1.04M0.07%Jun 30, 2026
Simplify Propel Opportunities ETF450,5430.26%$941.63K1.22%Jun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF380,6730.22%$795.61K0.00%Jun 30, 2026
Schwab Small-Cap Index Fund358,9830.21%$680.27K0.01%Jul 31, 2026
Master Small Cap Index Series275,8990.16%$576.63K0.01%Jun 30, 2026
Fidelity Total Market Index Fund269,2120.15%$570.73K0.00%May 31, 2026
iShares Russell 2000 Growth ETF246,4050.14%$514.99K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
John David FinleyCEO CFO, Director2,033,1411.17%Oct 7, 2026
Julien E. CapersSee Remarks787,3000.45%Oct 21, 2026
Mitchell Lawrence JonesSee Remarks1,683,7570.97%Oct 7, 2026
Donald Allen WilliamsDirector1,593,2940.91%Oct 5, 2026
Robert Baltera Jr.Director461,9040.27%Jul 10, 2026
Binxian WeiDirector613,3550.35%Jun 12, 2026
Emil ChuangDirector612,5000.35%Jun 12, 2026
Jordan Michael ZwickDirector336,9040.19%Jun 12, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Julien E. Capers
See Remarks
Oct 19, 2026Award+787,300––787,300
Mitchell Lawrence Jones
See Remarks
Oct 6, 2026Tax withholding−1,031,102$1.49$1.54M1,683,757
Mitchell Lawrence Jones
See Remarks
Oct 6, 2026Option exercise+2,620,850––2,714,859
John David Finley
CEO CFO, Director
Oct 6, 2026Tax withholding−1,411,982$1.49$2.10M1,944,690
John David Finley
CEO CFO, Director
Oct 6, 2026Option exercise+3,227,384––3,356,672
Donald Allen Williams
Director
Oct 2, 2026Buy+10,000$1.46$14.60K1,590,294
Donald Allen Williams
Director
Oct 1, 2026Buy+10,000$1.42$14.20K1,580,294
John David Finley
CEO, CFO, Director
Aug 19, 2026Gift−88,400––129,288
John David Finley
CEO, CFO, Director
Aug 19, 2026Gift+88,400––88,451
Robert Baltera Jr.
Director
Jul 9, 2026Buy+25,000$1.96$49.00K461,904
Robert Baltera Jr.
Director
Jul 8, 2026Buy+20,000$1.99$39.80K436,904
John David Finley
CEO, CFO, Director
Jul 7, 2026Sale−146,798$2.07$303.87K217,555
John David Finley
CEO, CFO, Director
Jul 7, 2026Option exercise+133$0.70$93217,688
Robert Baltera Jr.
Director
Jul 7, 2026Buy+30,000$2.03$60.90K416,904
Mitchell Lawrence Jones
Chief Medical Officer
Jul 7, 2026Sale−51,880$2.05$106.35K94,009
John David Finley
CEO, CFO, Director
Jul 6, 2026Option exercise+335,167––364,353
Robert Baltera Jr.
Director
Jul 6, 2026Buy+20,000$2.05$41.00K386,904
Mitchell Lawrence Jones
Chief Medical Officer
Jul 6, 2026Option exercise+131,167––145,889
Robert Baltera Jr.
Director
Jul 2, 2026Buy+10,000$1.98$19.80K366,904
Robert Baltera Jr.
Director
Jul 1, 2026Buy+20,000$1.98$39.60K356,904
Robert Baltera Jr.
Director
Jun 10, 2026Award+336,904––336,904
Jordan Michael Zwick
Director
Jun 10, 2026Award+336,904––336,904
Donald Allen Williams
Director
Jun 10, 2026Award+1,498,900––1,509,628
Donald Allen Williams
Director
Jun 10, 2026Option exercise+60,666––1,570,294
Emil Chuang
Director
Jun 10, 2026Option exercise+20,200––612,500
Emil Chuang
Director
Jun 10, 2026Award+592,300––592,300
Binxian Wei
Director
Jun 10, 2026Option exercise+20,200––613,355
Binxian Wei
Director
Jun 10, 2026Award+592,300––593,155
Mitchell Lawrence Jones
Chief Medical Officer
Feb 12, 2026Sale−1,989$1.75$3.48K13,263
John David Finley
CEO, CFO, Director
Feb 12, 2026Sale−3,896$1.75$6.82K27,353
Mitchell Lawrence Jones
Chief Medical Officer
Feb 11, 2026Option exercise+8,000––15,252
John David Finley
CEO, CFO, Director
Feb 11, 2026Option exercise+13,333––31,249
Donald Allen Williams
Director
Jan 16, 2026Buy+5,000$1.67$8.35K10,728
Donald Allen Williams
Director
Jan 9, 2026Buy+5,000$1.88$9.40K5,728
Binxian Wei
Director
Nov 21, 2024Option exercise+388––855
Donald Allen Williams
Director
Nov 21, 2024Option exercise+388––728
Donald Allen Williams
Director
Jun 11, 2024Option exercise+340––340
Binxian Wei
Director
Jun 11, 2024Option exercise+465––467
John David Finley
CEO, CFO, Director
May 28, 2024Option exercise+2,111––14,079
John David Finley
CEO, CFO, Director
May 28, 2024Option exercise+1,622––10,059
John David Finley
CEO, CFO, Director
May 28, 2024Tax withholding−467$4.76$2.22K9,592
John David Finley
CEO, CFO, Director
May 28, 2024Option exercise+3,335––12,927
John David Finley
CEO, CFO, Director
May 28, 2024Tax withholding−959$4.76$4.56K11,968
John David Finley
CEO, CFO, Director
May 28, 2024Tax withholding−607$4.76$2.89K13,472
Mitchell Lawrence Jones
Chief Medical Officer
May 28, 2024Tax withholding−461$4.76$2.19K3,852
Mitchell Lawrence Jones
Chief Medical Officer
May 28, 2024Option exercise+2,735––3,568
Mitchell Lawrence Jones
Chief Medical Officer
May 28, 2024Tax withholding−810$4.76$3.86K2,758
Mitchell Lawrence Jones
Chief Medical Officer
May 28, 2024Option exercise+1,555––4,313
Donald Allen Williams
Director
May 28, 2024Buy+1,000$4.86$4.86K1,000
John David Finley
CEO, CFO, Director
May 24, 2024Buy+1,000$4.81$4.81K8,437
John David Finley
CEO, CFO, Director
May 20, 2024Award+666$4.97$3.31K7,437
Mitchell Lawrence Jones
CEO, CFO, Director
May 6, 2024Tax withholding−90$8.46$761724
Mitchell Lawrence Jones
CEO, CFO, Director
May 6, 2024Option exercise+156––880
Mitchell Lawrence Jones
CEO, CFO, Director
May 6, 2024Tax withholding−47$8.46$398833
Mitchell Lawrence Jones
CEO, CFO, Director
May 6, 2024Option exercise+304––814
John David Finley
CEO, CFO, Director
May 6, 2024Tax withholding−67$8.46$5676,621
John David Finley
CEO, CFO, Director
May 6, 2024Option exercise+211––6,832
John David Finley
CEO, CFO, Director
May 6, 2024Tax withholding−61$8.46$5166,771
John David Finley
CEO, CFO, Director
May 6, 2024Option exercise+232––6,688
John David Finley
CEO, CFO, Director
Mar 11, 2024Option exercise+5,558––96,849

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
17.63%
29M shares short
Days to cover
7.8
At 4M shares a day
Change since last report
-7.7%
From 32M shares
Short volume, 20 days
29.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Palisade Bio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 195,218 shares on Sep 22, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
John David Finley
Officer
Jul 7, 2026146,798$303.34KJul 7, 2026RSU Vesting
Mitchell Lawrence Jones
Officer
Jul 7, 202653,000$108.12KJul 7, 2026RSU

See a number that looks wrong?